Department of Pharmacology & Chemical Biology at the University of Pittsburgh
Vera Procaccia
Graduate Student Researcher


Bisello Lab

W1313 Thomas E. Starzl Biomedical Science Tower


BSc Med, Basic Medical Sciences, The Hebrew University, 2005
MSc, Developmental Biology, The Hebrew University, 2009

Awards Received
Louis J. Ignarro Cardiovascular Pharmacology Fellowship 2015

Faculty Mentor
Dr. Alessandro Bisello
W1313 Thomas E. Starzl Biomedical Science Tower
Photo of Vera Procaccia

Procaccia V, Nakayama H, Shimizu A, Klagsbrun M.Gleevec/imatinib, an ABL2 kinase inhibitor, protects tumor and endothelial cells from semaphorin-induced cytoskeleton collapse and loss of cell motility. Biochem Biophys Res Commun. 2014 May 30;448(2):134-8. doi: 10.1016/j.bbrc.2014.04.063. Epub 2014 Apr 20. PMID: 24759231 PMCID: PMC4068341

Back to Top